ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Aortic valve disease

November 28, 2016
An extremely important journal article comprised of two case reports involving valve perforation and insufficiency following use of the Cor-Knot Automated Fastener (LSI Solutions, Victor, NY, USA) during valve replacement.
November 23, 2016
Early single institution experience with minimally invasive sutureless aortic valve replacement was reported.  Among 300 patients, surgeon-specific and institution-specific learning curves were evaluated for technical success and 30-day complications.  A cluster of complications occurred early in the experience and then standardized.  No significant
November 23, 2016
Valve in valve transcatheter aortic valve implantation (ViV-TAVI) is an alternative to redo surgical aortic valve replacement (SAVR) in inoperable patients and inpatients at high operative risk.
October 31, 2016
This single institution study evalated the effect of prosthesis choice on regression of LV mass after AVR in patients with AS.  The St.
October 31, 2016
This single institution retrospective study evaluated outcomes of valve replacement for degenerated bioprosthetic aortic valves comparing surgical AVR (SAVR) to transcatheter valve-in-valve procedures (TViV).  Patients were matched into 2 groups of 22 according to STS risk scores.   Operative mortality, stroke rate, and 3-year survival were similar b
October 13, 2016
This is the first report of the use of a balloon expandable transcatheter heart valve (Edwards Sapiens 3) for TAVI in chronic aortic regurgitation (AR) involving non-calcified native valves. The authors implanted Edwards Sapiens 3 prostheses in three patients with severe AR deemed inoperable by the heart team.
October 13, 2016
This single center retrospective study analyzed the incidence of permanent pacemaker requirement in 108 consecutive patients undergoing sutureless aortic valve replacement with the Perceval S bioprosthesis.
September 27, 2016
This analysis of PARTNER data evaluated the impact of chronic kidney disease (CKD) on outcomes after TAVR.  Patients were grouped according to GFR as none/mild, moderate, and severe renal disease.  Severe disease was most common among women with diabetes.
September 27, 2016
This single institution retrospective review assessed outcomes of AVR in patients with concomitant aortic root disease using a composite graft.  Early mortality was 5.3% and was related to advanced age, poor NYHA status, urgent operation, and associated MVR or CABG.
September 27, 2016
The authors demonstrate how to perform mitroaortic replacement using the David Technique in a case of prosthethic endocarditis.

Pages